Raising High-Density Lipoprotein Levels: Out with the New, In with the Old?

lipoprotein, high-density, low-density, HDL, LDL, torcetrapib, lipid, lipids, Lipid Level Management to Understand its Impact in Atherosclerotic Events, ILLUMINATE, cholesteryl ester transfer protein, CETP, niacin, nicotinic acid, fibrates, thiazolidinediones, glitazones, flushing, Niaspan, Arterial Disease Multiple Intervention Trial, ADMIT, Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial, ADVENTlipoprotein, high-density, low-density, HDL, LDL, torcetrapib, lipid, lipids, Lipid Level Management to Understand its Impact in Atherosclerotic Events, ILLUMINATE, cholesteryl ester transfer protein, CETP, niacin, nicotinic acid, fibrates, thiazolidinediones, glitazones, flushing, Niaspan, Arterial Disease Multiple Intervention Trial, ADMIT, Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial, ADVENT

lipoprotein, high-density, low-density, HDL, LDL, torcetrapib, lipid, lipids, Lipid Level Management to Understand its Impact in Atherosclerotic Events, ILLUMINATE, cholesteryl ester transfer protein, CETP, niacin, nicotinic acid, fibrates, thiazolidinediones, glitazones, flushing, Niaspan, Arterial Disease Multiple Intervention Trial, ADMIT, Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial, ADVENTlipoprotein, high-density, low-density, HDL, LDL, torcetrapib, lipid, lipids, Lipid Level Management to Understand its Impact in Atherosclerotic Events, ILLUMINATE, cholesteryl ester transfer protein, CETP, niacin, nicotinic acid, fibrates, thiazolidinediones, glitazones, flushing, Niaspan, Arterial Disease Multiple Intervention Trial, ADMIT, Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial, ADVENT

lipoprotein, high-density, low-density, HDL, LDL, torcetrapib, lipid, lipids, Lipid Level Management to Understand its Impact in Atherosclerotic Events, ILLUMINATE, cholesteryl ester transfer protein, CETP, niacin, nicotinic acid, fibrates, thiazolidinediones, glitazones, flushing, Niaspan, Arterial Disease Multiple Intervention Trial, ADMIT, Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial, ADVENTlipoprotein, high-density, low-density, HDL, LDL, torcetrapib, lipid, lipids, Lipid Level Management to Understand its Impact in Atherosclerotic Events, ILLUMINATE, cholesteryl ester transfer protein, CETP, niacin, nicotinic acid, fibrates, thiazolidinediones, glitazones, flushing, Niaspan, Arterial Disease Multiple Intervention Trial, ADMIT, Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial, ADVENT